Loading clinical trials...
Loading clinical trials...
Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type Colorectal Cancer in First-line Treatment: a Prospective, Observational Multi-centre Study in Spain. PERSEIDA Study
Conditions
Locations
24
Spain
Research Site
Almería, Andalusia, Spain
Research Site
Granada, Andalusia, Spain
Research Site
Seville, Andalusia, Spain
Research Site
Palma de Mallorca, Balearic Islands, Spain
Research Site
San Cristóbal de La Laguna, Canary Islands, Spain
Research Site
Burgos, Castille and León, Spain
Start Date
May 6, 2016
Primary Completion Date
May 31, 2021
Completion Date
May 31, 2021
Last Updated
May 13, 2024
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions